A 59-year-old man was diagnosed to have idiopathic myelofibrosis (IMF) 
Introduction

Portal hypertension occurs in approximately 10% of all patients with myelofibrosis (1). Portal hypertension associated with myelofibrosis is known to have a poor prognosis (1). In the fibrotic stage of the idiopathic myelofibrosis (IMF), bone marrow fibrosis results in ineffective erythropoiesis, thus leading to extramedullary hematopoiesis, mainly in the spleen and the liver (2). Here, we report a case of IMF with intractable ascites and portal hypertension who was successfully treated with an implantation of a transjugular intrahepatic portosystemic shunt (TIPS).
Case Report
F i g u r e 1 . Cl i n i c a l c o u r s e o f t h i s c a s e
T a b l e 1 . L a b o r a t o r y Da t a o n Ad mi s s i o n day 74 after TIPS, his waist measured 68 cm only due to diuretic drugs (Fig. 1). The diuretic drugs were gradually tapered and he was only given oral drugs from day 74 after TIPS. The ascites improved in the presence of unchanged serum protein levels
. The spleen showed congestive swelling (650 g) and the red pulp was enlarged. In addition, no esophageal varices were found. Severe hemosiderosis due to transfusion was found in the liver, spleen, pancreas, kidney, adrenal gland, stomach, and thyroid gland.
Discussion
Portal hypertension in patients with myelofibrosis may have various causes: thrombosis of the hepatic vein, thrombosis of the portal vein, and infiltration of the liver or spleen by myeloid cells (3-5). An increased hepatic blood flow by extramedullary hematopoiesis causes sinusoidal fibrosis and nodular regenerative hyperplasia, which are conditions known to induce portal hypertension (3-5). Wiest et
F i g u r e 2 . L i v e r f u n c t i o n l e v e l o f t h i s c a s e
F i g u r e 3 . Au t o p s y f i n d i n g s ( × 4 0 0 , s i l v e r i mp r e g n a t i o n s t a i n i n g ) S i n u s o i d a l f i b r o s i s wa s f o u n d i n t h e l i v e r . P e r i s i n u s o i d a l c o l l a g e n n e t wo r k wa s i n c r e a s e d c o mp a r e d wi t h c o n t r o l .
al (6) proposed that an obstruction of the presinusoidal space secondary to extramedullary haemotopoesis of the liver may only play a minor role in the development of clinically significant portal hypertension.
In the present case, we observed sinusoidal fibrosis but no thrombosis. The sinusoidal fibrosis may have been due to a reaction for an increased hepatic blood flow and extramedullary hematopoiesis in the liver (3) (4) (5) . On the other hand, liver cirrhosis demonstrates chronic progressive fibrosis of the liver, and the area of fibrosis is the hepatocytes (7) . In this case, the area of fibrosis was the sinusoids, not the hepatocytes as is normally seen in cirrhosis.
Platelets and megakaryocytes contain large amounts of growth factors, including platelet-derived growth factor and transforming growth factor beta, which have both been shown to stimulate the proliferation of fibroblasts (3, 8) . Platelets and megakaryocytes in the space of Disse in the liver ultrastructurally contain extramedullary hematopoiesis (3, 9 (10, 11) . This is also a good method for managing portal hypertension in patients with IMF (6, 12, 13) . Kobayashi et al (14) 
